Key considerations in targeted protein degradation drug discovery and development

HIGHLIGHTS

  • who: Protein Degradation Drug Discovery and collaborators from the University, Hefei, China have published the research: Key Considerations in Targeted Protein Degradation Drug Discovery and Development, in the Journal: (JOURNAL)
  • how: The molecules were tested in the HEK293 T_cell line transduced with FLAG-tagged FKBP12 either with or without C-terminal NLS (nuclear localization sequence) KKKRKV.

SUMMARY

    E3 ligases beyond VHL and CRBN for targeted protein degradation, for example, tissue-specific or diseasespecific E3 ligases would considerably expand the application of targeted protein degradation for therapeutic purposes (Kannt and Đikić 2021 . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?